These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14525593)

  • 1. Prevention of CD40-triggered dendritic cell maturation and induction of T-cell hyporeactivity by targeting of Janus kinase 3.
    Säemann MD; Diakos C; Kelemen P; Kriehuber E; Zeyda M; Böhmig GA; Hörl WH; Baumruker T; Zlabinger GJ
    Am J Transplant; 2003 Nov; 3(11):1341-9. PubMed ID: 14525593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
    Doucet C; Giron-Michel J; Canonica GW; Azzarone B
    Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
    Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
    Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
    J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells.
    Servet-Delprat C; Vidalain PO; Bausinger H; Manié S; Le Deist F; Azocar O; Hanau D; Fischer A; Rabourdin-Combe C
    J Immunol; 2000 Feb; 164(4):1753-60. PubMed ID: 10657621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 on adult human airway epithelial cells: expression and proinflammatory effects.
    Cagnoni F; Oddera S; Giron-Michel J; Riccio AM; Olsson S; Dellacasa P; Melioli G; Canonica GW; Azzarone B
    J Immunol; 2004 Mar; 172(5):3205-14. PubMed ID: 14978128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 triggered human monocyte-derived dendritic cells convert to tolerogenic dendritic cells when JAK3 activity is inhibited.
    Säemann MD; Kelemen P; Zeyda M; Böhmig G; Staffler G; Zlabinger GJ
    Transplant Proc; 2002 Aug; 34(5):1407-8. PubMed ID: 12176418
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of CD40 ligation and interferon-gamma on functional properties of human monocyte-derived dendritic cells activated with polyinosinic-polycytidylic acid.
    Dragicević A; Dzopalić T; Vasilijić S; Vucević D; Bozić B; Majstorović I; Balint B; Colić M
    Vojnosanit Pregl; 2011 Apr; 68(4):301-8. PubMed ID: 21627015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
    McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
    J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice.
    Suzuki K; Nakajima H; Saito Y; Saito T; Leonard WJ; Iwamoto I
    Int Immunol; 2000 Feb; 12(2):123-32. PubMed ID: 10653847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jak3 negatively regulates dendritic-cell cytokine production and survival.
    Yamaoka K; Min B; Zhou YJ; Paul WE; O'shea JJ
    Blood; 2005 Nov; 106(9):3227-33. PubMed ID: 16020505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma(c) chain for Janus kinase activation leading to T cell proliferation.
    Nelson BH; McIntosh BC; Rosencrans LL; Greenberg PD
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1878-83. PubMed ID: 9050873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Janus Kinase 3 on Cellular Ca Release, Store Operated Ca(2+) Entry and Na(+)/Ca(2+) Exchanger Activity in Dendritic Cells.
    Yan J; Schmid E; Hosseinzadeh Z; Honisch S; Shumilina E; Fuchs J; Lang F
    Cell Physiol Biochem; 2015; 36(6):2287-98. PubMed ID: 26279433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of JAK3 in CD40-mediated signaling.
    Jabara HH; Buckley RH; Roberts JL; Lefranc G; Loiselet J; Khalil G; Geha RS
    Blood; 1998 Oct; 92(7):2435-40. PubMed ID: 9746783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells.
    Hanissian SH; Geha RS
    Immunity; 1997 Apr; 6(4):379-87. PubMed ID: 9133417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells.
    Kirken RA; Erwin RA; Taub D; Murphy WJ; Behbod F; Wang L; Pericle F; Farrar WL
    J Leukoc Biol; 1999 Jun; 65(6):891-9. PubMed ID: 10380915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40-mediated regulation of interleukin-4 signaling pathways in B lymphocytes.
    Siepmann K; Wohlleben G; Gray D
    Eur J Immunol; 1996 Jul; 26(7):1544-52. PubMed ID: 8766559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin.
    Stepkowski SM; Erwin-Cohen RA; Behbod F; Wang ME; Qu X; Tejpal N; Nagy ZS; Kahan BD; Kirken RA
    Blood; 2002 Jan; 99(2):680-9. PubMed ID: 11781254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Janus kinase 3-STAT5a pathway after CD40 triggering of human monocytes but not of resting B cells.
    Revy P; Hivroz C; Andreu G; Graber P; Martinache C; Fischer A; Durandy A
    J Immunol; 1999 Jul; 163(2):787-93. PubMed ID: 10395671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.